Therapeutic Efficacy of YM155 to Regulate an Epigenetic Enzyme in Major Subtypes of RCC

Renal cell carcinoma (RCC) is the most common type of kidney cancer and includes more than 10 subtypes. Compared to the intensively investigated clear cell RCC (ccRCC), the underlying mechanisms and treatment options of other subtypes, including papillary RCC (pRCC) and chromogenic RCC (chRCC), are...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of molecular sciences 2023-12, Vol.25 (1), p.216
Hauptverfasser:	Hong, Seong Hwi, Lee, Young Ju, Jang, Eun Bi, Hwang, Hyun Ji, Kim, Eun Song, Son, Da Hyeon, Park, Sung Yul, Moon, Hong Sang, Yoon, Young Eun
Format:	Artikel
Sprache:	eng
Schlagworte:	Antimitotic agents Antineoplastic agents Apoptosis Cancer Cancer therapies Carcinoma, Renal Cell - drug therapy Carcinoma, Renal Cell - genetics Cells Chromatin Comparative analysis Enzymes Epigenesis, Genetic Epigenetic inheritance Genes Health aspects Humans Imidazoles Immunohistochemistry Kidney cancer Kidney Neoplasms - drug therapy Kidney Neoplasms - genetics Kinases Naphthoquinones - pharmacology Naphthoquinones - therapeutic use Oncology, Experimental Scientific equipment and supplies industry Tumors Wound healing
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!